Young Li
Stock Analyst at Jefferies
(0.22)
# 4,278
Out of 4,959 analysts
6
Total ratings
33.33%
Success rate
-31.86%
Average return
Main Sectors:
Stocks Rated by Young Li
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| RXST RxSight | Downgrades: Hold | $24 → $9 | $9.28 | -3.02% | 2 | Jul 10, 2025 | |
| COO The Cooper Companies | Upgrades: Buy | $107 → $115 | $75.22 | +52.88% | 1 | Jul 16, 2024 | |
| HYPR Hyperfine | Initiates: Hold | $1.25 | $1.30 | -3.47% | 1 | Nov 30, 2023 | |
| ENOV Enovis | Initiates: Buy | $60 | $31.44 | +90.84% | 1 | Oct 12, 2022 | |
| ANIK Anika Therapeutics | Initiates: Neutral | $46 | $9.65 | +376.68% | 1 | Jul 16, 2021 |
RxSight
Jul 10, 2025
Downgrades: Hold
Price Target: $24 → $9
Current: $9.28
Upside: -3.02%
The Cooper Companies
Jul 16, 2024
Upgrades: Buy
Price Target: $107 → $115
Current: $75.22
Upside: +52.88%
Hyperfine
Nov 30, 2023
Initiates: Hold
Price Target: $1.25
Current: $1.30
Upside: -3.47%
Enovis
Oct 12, 2022
Initiates: Buy
Price Target: $60
Current: $31.44
Upside: +90.84%
Anika Therapeutics
Jul 16, 2021
Initiates: Neutral
Price Target: $46
Current: $9.65
Upside: +376.68%